Innovative Cancer Drug Developer Jeff Geschwind, MD is the founder of Cage Pharma. His research focuses on innovative cancer drugs that target tumor metabolism, specifically glycolysis. This groundbreaking approach by Jeff Geschwind, MD seeks to cut off the energy supply to cancer cells, offering a new potential weapon against aggressive tumors. https://www.linkedin.com/in/jeff-geschwind-037200174